Seek truth from facts, competitive symbiosis
Zhengqing Fengtongning Shines on the International Academic Stage! Chairman Wu Feichi Elected Vice President; Brand Strength Recognized.
Category:
Release time:
2025-11-24
From November 21 to 23, 2025, the Inaugural Meeting of the Rheumatology Professional Committee of the World Federation of Chinese Medicine Societies and the 2025 Academic Annual Conference were grandly held at the Kyoto Xinyuan Hotel in Beijing. Centered around the theme of “Inheriting and Innovating, Promoting Sino-Western Collaboration,” this conference brought together top rheumatology experts, scholars, and industry leaders from multiple countries and regions. Participants engaged in in-depth discussions on key topics such as the clinical application of toxic Chinese herbs, the inheritance of experience from renowned veteran Chinese medicine practitioners, and integrated Chinese and Western medical research—both in clinical practice and basic science.
As a leading representative of the Chinese medicine industry, Dr. Wu Feichi, Chairman of Zhengqing Group, was invited to attend this grand event. During the conference’s leadership transition and election, Chairman Wu Feichi was re-elected as Vice President of the 4th Council of the Rheumatology Professional Committee of the World Federation of Chinese Medicine Societies, thanks to his profound experience and outstanding contributions in innovative R&D and industry promotion within the field of Chinese medicine. This honor not only recognizes Dr. Wu Feichi’s personal professional achievements but also underscores the Group’s significant industry standing and influence in the global diagnosis and treatment of rheumatic diseases through Chinese medicine, laying a solid foundation for the company to further participate in the formulation of industry standards and drive the advancement of this discipline.
During the conference, Zhengqing Group’s flagship product, Zhengqing Fengtongning, became an academic focal point and received intense attention and high praise from the attending authoritative experts. In his special report, Professor Dong Zhenhua from Peking Union Medical College Hospital (Vice President of the Rheumatology Professional Committee of the World Federation of Chinese Medicine Societies) systematically reviewed the modern research trajectory—from the traditional Chinese herb Qingfengteng to its core active ingredient, sinomenine—and provided an in-depth analysis of sinomenine’s well-defined pharmacological mechanisms in anti-inflammation, pain relief, and immune modulation, setting a remarkable example for the modern development of active ingredients from traditional Chinese medicine.
In his report, Professor Dong Zhenhua specifically pointed out that the Zhengqing Fengtongning series of preparations—whose sole active ingredient is sinomenine—have been included in numerous clinical practice guidelines and expert consensuses issued by authoritative organizations such as the Chinese Association of Traditional Chinese Medicine, thanks to their proven clinical efficacy and solid scientific evidence. These preparations are widely used in the clinical treatment of rheumatic diseases, including rheumatoid arthritis. This official recognition fully underscores Zhengqing Fengtongning’s central academic standing and significant clinical value in the field of rheumatic disease treatment, and also provides strong support for clinicians’ standardized medication practices.
This appearance on a world-class academic platform not only serves as an authoritative endorsement of the scientific essence and therapeutic advantages of Zhengqing Fengtongning products, but also vividly demonstrates the Group’s commitment to the development philosophy of “carrying forward the best traditions while upholding integrity and fostering innovation.” In the future, the Group will continue to deepen its research into the modernization and internationalization of traditional Chinese medicine. Taking this academic exchange as a vital link, we will actively engage in collaborative academic efforts and industry development within the global field of TCM rheumatology, constantly enhancing the core competitiveness and clinical value of our products. Relying on our accumulated expertise and breakthroughs in the treatment of rheumatic diseases, we will bring professional rehabilitation solutions to more patients, promote and apply TCM’s academic achievements worldwide, and contribute the power of TCM to the cause of human health!
Copyright Hunan Zhengqing Pharmaceutical Group Co., Ltd.
Virtual Showroom：
Agent：
OA：
CRM：
在线客服添加返回顶部
右侧在线客服样式 1,2,3 1
图片alt标题设置： Hunan Zhengqing Pharmaceutical Group Co., Ltd.
表单验证提示文本： Please enter correct content!
循环体没有内容时： Updating......
CSS / JS 文件放置地